Cas No. 180637-88-1, Eletriptan

Eletriptan, a selective serotonin receptor agonist, has proven efficacious in the treatment of migraines, reducing symptoms such as headache and nausea. Our top-notch intermediates guarantee a streamlined production process, ensuring reliable and timely manufacturing of this game-changing medication. Partner with us to transform the management of migraine, providing patients with a reliable and effective treatment option. Join the Eletriptan revolution and make a difference in neurological care.